TW202027731A - Capsule - Google Patents

Capsule Download PDF

Info

Publication number
TW202027731A
TW202027731A TW108145625A TW108145625A TW202027731A TW 202027731 A TW202027731 A TW 202027731A TW 108145625 A TW108145625 A TW 108145625A TW 108145625 A TW108145625 A TW 108145625A TW 202027731 A TW202027731 A TW 202027731A
Authority
TW
Taiwan
Prior art keywords
gelatin
mass
oil
content
film
Prior art date
Application number
TW108145625A
Other languages
Chinese (zh)
Inventor
鳥井一宏
要田涼太
渋谷忠杜
岡野美優
Original Assignee
日商小林製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商小林製藥股份有限公司 filed Critical 日商小林製藥股份有限公司
Publication of TW202027731A publication Critical patent/TW202027731A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate

Abstract

The purpose of the present invention is to provide a novel means capable of suppressing insolubilization of a coating that includes gelatin. Provided is a capsule characterized in that an ingredient that comprises at least one selected from the group consisting of peppermint oil, parsley seed oil, and menthone oil is contained in a coating that comprises at least one selected from the group consisting of pig-derived gelatin and fish-derived gelatin.

Description

膠囊劑Capsules

本發明是有關於一種膠囊劑。The present invention relates to a capsule.

明膠對人體無毒性且廉價,並且膠形成能力、增黏性等優異。因此,明膠作為膠囊劑的成分廣泛用於醫藥或食品等領域中,其中,源自牛的明膠廣泛用作膠囊劑的成分。Gelatin is non-toxic to the human body and inexpensive, and has excellent gel forming ability and viscosity increasing properties. Therefore, gelatin is widely used as a component of capsules in the fields of medicine or food, among which gelatin derived from cattle is widely used as a component of capsules.

但是,於將明膠用作膠囊劑的皮膜的情況下,有因與填充於膠囊中的內容物的交聯反應等而皮膜的溶解性容易經時性降低的傾向。此種溶解性的降低導致皮膜的不溶化,例如導致無法適當放出有效成分等不良情況。因此,於膠囊劑中,皮膜的不溶化會引起品質降低等嚴重問題。However, when gelatin is used as the film of the capsule, the solubility of the film tends to decrease over time due to a crosslinking reaction with the contents filled in the capsule. Such a decrease in solubility leads to insolubilization of the film, and for example, causes problems such as inability to properly release the active ingredient. Therefore, in the capsule, the insolubilization of the film causes serious problems such as quality degradation.

迄今為止,作為抑制皮膜的不溶化的方法,例如已知有如下方法:將肌醇磷酸調配於明膠中而製作皮膜用組成物,並將其用作膠囊劑的皮膜(專利文獻1)。雖然以往知曉此種方法,但重要的是進而提供一種可抑制皮膜的不溶化的新的方法。 [現有技術文獻] [專利文獻]Heretofore, as a method of suppressing insolubilization of a film, for example, a method is known in which inositol phosphate is formulated in gelatin to prepare a composition for a film, and this is used as a film of a capsule (Patent Document 1). Although this method is known in the past, it is important to provide a new method that can suppress the insolubilization of the film. [Prior Art Literature] [Patent Literature]

[專利文獻1]日本專利特開2006-328038號公報[Patent Document 1] Japanese Patent Laid-Open No. 2006-328038

[發明所欲解決之課題][The problem to be solved by the invention]

本發明的目的在於提供一種可抑制包含明膠的皮膜的不溶化的新的方法。 [解決課題之手段]The object of the present invention is to provide a new method that can suppress the insolubilization of a film containing gelatin. [Means to solve the problem]

本發明者等人鑒於所述課題而進行了努力研究,結果發現:與將薄荷油(peppermint oil)、香芹籽油(parsley seed oil)或薄荷酮油(menthone oil)和源自牛的明膠併用的情況相比,於將所述成分與源自豬或源自魚的明膠併用的情況下,可有效地抑制明膠的不溶化。基於所述見解並進一步反覆研究,結果完成了本發明,且如下所述。The inventors of the present invention conducted diligent studies in view of the above-mentioned problems, and found that they are combined with peppermint oil, parsley seed oil or menthone oil and bovine-derived gelatin. Compared with the combined use, the insolubilization of gelatin can be effectively suppressed when the above component is used in combination with gelatin derived from pig or fish. Based on these findings and further repeated studies, the present invention was completed as a result, as described below.

項1.一種膠囊劑,其特徵在於:於皮膜中內包有內容物,所述皮膜含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種,所述內容物含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種。 項2.如項1所述的膠囊劑,其中內容物更含有三酸甘油酯,該內容物中,相對於該三酸甘油酯100質量份而含有28質量份以下的薄荷油。 項3.如項1或項2所述的膠囊劑,其中內容物更含有三酸甘油酯,該內容物中,相對於該三酸甘油酯100質量份而含有28質量份以下的香芹籽油。 項4.如項1至項3中任一項所述的膠囊劑,其中內容物更含有三酸甘油酯,該內容物中,相對於該三酸甘油酯100質量份而含有28質量份以下的薄荷酮油。 項5.如項1至項4中任一項所述的膠囊劑,其為軟膠囊劑。 項6.一種皮膜的不溶化抑制方法,其特徵在於:於具有內容物及內包所述內容物的皮膜的膠囊劑中,將含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種的內容物、與含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的皮膜組合。 [發明的效果]Item 1. A capsule, characterized in that: a skin film contains a content which contains at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin, the content The substance contains at least one selected from the group consisting of peppermint oil, caraway oil and menthone oil. Item 2. The capsule according to Item 1, wherein the content further contains triglyceride, and the content contains 28 parts by mass or less of peppermint oil with respect to 100 parts by mass of the triglyceride. Item 3. The capsule according to item 1 or 2, wherein the content further contains triglyceride, and the content contains 28 parts by mass or less of caraway relative to 100 parts by mass of the triglyceride oil. Item 4. The capsule according to any one of items 1 to 3, wherein the content further contains triglyceride, and the content contains 28 parts by mass or less with respect to 100 parts by mass of the triglyceride Menthone oil. Item 5. The capsule according to any one of Items 1 to 4, which is a soft capsule. Item 6. A method for inhibiting insolubilization of a film, characterized in that: a capsule having a content and a film encapsulating the content contains one selected from peppermint oil, caraway oil, and menthone oil At least one content in the group is combined with a film containing at least one selected from the group consisting of pig-derived gelatin and fish-derived gelatin. [Effects of the invention]

根據本發明的膠囊劑或方法,可抑制含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的皮膜的不溶化。According to the capsule or method of the present invention, the insolubilization of the film containing at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin can be suppressed.

本發明提供一種膠囊劑,其特徵在於:含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種的內容物內包於皮膜中,所述皮膜含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種。The present invention provides a capsule, which is characterized in that at least one content selected from the group consisting of peppermint oil, caraway oil, and menthone oil is contained in a film, and the film contains At least one of the group consisting of porcine-derived gelatin and fish-derived gelatin.

內容物 於本發明的膠囊劑中,內容物含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種。Contents In the capsule of the present invention, the content contains at least one selected from the group consisting of peppermint oil, caraway oil and menthone oil.

薄荷油為藉由水蒸氣蒸餾對薄荷的地上部分進行精製而獲得的精油,且作為CAS No.8006-90-4亦為人所知。薄荷油可商業性獲取,例如作為薄荷白油(長岡實業股份有限公司製造)、日本藥局方薄荷油(小川香料股份有限公司製造)等而市售。Peppermint oil is an essential oil obtained by refining the aerial part of peppermint by steam distillation, and is also known as CAS No. 8006-90-4. Peppermint oil is commercially available, for example, as peppermint white oil (manufactured by Nagaoka Industrial Co., Ltd.), peppermint oil (manufactured by Ogawa Fragrance Co., Ltd.) and the like.

內容物中的薄荷油的含量並無限制,可例示:較佳為0.2質量%~22質量%、更佳為0.5質量%~20質量%、尤佳為1質量%~10質量%。The content of peppermint oil in the content is not limited, and examples thereof are preferably 0.2% by mass to 22% by mass, more preferably 0.5% by mass to 20% by mass, and particularly preferably 1% by mass to 10% by mass.

香芹籽油為由香芹的籽獲得的精油,且作為CAS No.8000-68-8亦為人所知。香芹籽油可商業性獲取,例如作為香芹籽油(香榮興業股份有限公司製造)等而市售。Caraway oil is an essential oil obtained from the seeds of parsley, and is also known as CAS No. 8000-68-8. Parsley oil is commercially available, for example, it is marketed as parsley oil (manufactured by Xiangrong Industrial Co., Ltd.).

內容物中的香芹籽油的含量並無限制,可例示:較佳為0.05質量%~22質量%、更佳為0.1質量%~10質量%、尤佳為0.15質量%~5質量%。The content of parsley oil in the content is not limited, and it can be exemplified: preferably 0.05% by mass to 22% by mass, more preferably 0.1% by mass to 10% by mass, and particularly preferably 0.15% by mass to 5% by mass.

將對屬於薄荷屬的植物進行水蒸氣蒸餾而得的精油分離為脫腦油與粗腦,此處,由分離而得的脫腦油獲得薄荷酮油。薄荷酮油可商業性獲取,例如作為薄荷酮油(長岡實業股份有限公司製造)等而市售。眾所周知,薄荷酮油含有薄荷酮作為主成分,所述薄荷油含有薄荷醇作為主成分。The essential oil obtained by steam distillation of plants belonging to the genus Peppermint is separated into de-brained oil and crude brain. Here, menthone oil is obtained from the separated de-brained oil. Menthone oil is commercially available, and for example, it is marketed as menthone oil (manufactured by Nagaoka Industrial Co., Ltd.). It is well known that menthone oil contains menthone as a main component, and the peppermint oil contains menthol as a main component.

內容物中的薄荷酮油的含量並無限制,可例示:較佳為1質量%~22質量%、更佳為3質量%~18質量%、尤佳為5質量%~15質量%。The content of menthone oil in the content is not limited, and examples thereof are preferably 1% by mass to 22% by mass, more preferably 3% by mass to 18% by mass, and particularly preferably 5% by mass to 15% by mass.

另外,雖並不限制本發明,但於本發明的內容物含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少兩種的情況下,關於內容物中的選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少兩種的含量,可例示:以總量計較佳為0.2質量%~30質量%、更佳為5質量%~25質量%、尤佳為10質量%~20質量%。In addition, although the present invention is not limited, when the content of the present invention contains at least two selected from the group consisting of peppermint oil, caraway oil, and menthone oil, regarding the selection of the content The content of at least two of the group consisting of free peppermint oil, caraway oil, and menthone oil can be exemplified: the total amount is preferably 0.2% by mass to 30% by mass, more preferably 5% by mass to 25% by mass. % By mass, particularly preferably 10% by mass to 20% by mass.

本發明的內容物雖於該限度內並無限制,但較佳為還含有三酸甘油酯。Although the content of the present invention is not limited within this limit, it is preferable to further contain triglycerides.

三酸甘油酯為具有三個脂肪酸酯結合於一個丙三醇的結構的化合物。酯結合於丙三醇的脂肪酸可為飽和脂肪酸,亦可為不飽和脂肪酸,另外,可為直鏈脂肪酸,亦可為分支鏈脂肪酸。該脂肪酸的碳數亦並無限制,可例示:較佳為碳數8~22、更佳為碳數10~21、尤佳為12~20的脂肪酸。雖於該限度內並無限制,但作為脂肪酸,可例示:辛酸、癸酸、月桂酸、肉豆蔻酸、棕櫚酸、棕櫚油酸、硬脂酸、油酸、亞麻油酸、次亞麻油酸、花生酸、山萮酸、木蠟酸等。結合於一個丙三醇的三個脂肪酸分別可相同,亦可僅兩種相同,亦可相互不同。三酸甘油酯可單獨使用一種,亦可組合使用兩種以上。Triglycerides are compounds having a structure in which three fatty acid esters are bonded to one glycerol. The fatty acid whose ester is bound to glycerol may be a saturated fatty acid or an unsaturated fatty acid. In addition, it may be a straight-chain fatty acid or a branched-chain fatty acid. The carbon number of the fatty acid is also not limited, and examples thereof include a fatty acid having 8 to 22 carbons, more preferably 10 to 21 carbons, and particularly preferably 12 to 20 carbons. Although there is no limitation within this limit, examples of fatty acids include caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, and linolenic acid. , Arachidic acid, behenic acid, lignoceric acid, etc. The three fatty acids bound to one glycerol may be the same, or only two of them may be the same, or different from each other. One type of triglyceride may be used alone, or two or more types may be used in combination.

三酸甘油酯例如於向日葵油、紅花油、菜籽油、橄欖油、棉籽油、大豆油、芝麻油、玉米油、花生油、葡萄油、椰子油等植物油、豬油、魚油、牛油等動物油等中亦大量含有。因此,於內容物中亦可使用該些植物油、動物油等。它們可單獨使用一種,亦可組合使用兩種以上。Triglycerides are for example in sunflower oil, safflower oil, rapeseed oil, olive oil, cottonseed oil, soybean oil, sesame oil, corn oil, peanut oil, grape oil, coconut oil and other vegetable oils, lard, fish oil, tallow and other animal oils, etc. It is also contained in large amounts. Therefore, these vegetable oils, animal oils, etc. can also be used in the contents. These may be used alone or in combination of two or more.

於本發明的內容物含有三酸甘油酯的情況下,雖並不限制本發明,但內容物中,相對於該三酸甘油酯100質量份,薄荷油可例示:較佳為28質量份以下、更佳為0.5質量份~27質量份、尤佳為0.5質量份~20質量份、特佳為1質量份~12質量份。In the case where the content of the present invention contains triglyceride, although the present invention is not limited, in the content, relative to 100 parts by mass of the triglyceride, peppermint oil can be exemplified: preferably 28 parts by mass or less , More preferably, it is 0.5 to 27 parts by mass, particularly preferably 0.5 to 20 parts by mass, and particularly preferably 1 to 12 parts by mass.

於本發明的內容物含有三酸甘油酯的情況下,雖並不限制本發明,但內容物中,相對於該三酸甘油酯100質量份,香芹籽油可例示:為28質量份以下、更佳為0.1質量份~27質量份、尤佳為0.2質量份~15質量份、特佳為0.2質量份~12質量份。In the case where the content of the present invention contains triglycerides, the present invention is not limited, but in the content, relative to 100 parts by mass of the triglycerides, caraway oil can be exemplified: 28 parts by mass or less , More preferably, it is 0.1 to 27 parts by mass, particularly preferably 0.2 to 15 parts by mass, and particularly preferably 0.2 to 12 parts by mass.

於本發明的內容物含有三酸甘油酯的情況下,雖並不限制本發明,但內容物中,相對於該三酸甘油酯100質量份,薄荷酮油可例示:為28質量份以下、更佳為1質量份~27質量份、尤佳為1質量份~20質量份、特佳為5質量份~20質量份。In the case where the content of the present invention contains triglycerides, the present invention is not limited, but in the content, menthone oil can be exemplified: 28 parts by mass or less, relative to 100 parts by mass of the triglycerides, It is more preferably 1 part by mass to 27 parts by mass, particularly preferably 1 part by mass to 20 parts by mass, and particularly preferably 5 parts by mass to 20 parts by mass.

內容物中的三酸甘油酯的含量並無限制,可例示:較佳為60質量%~99.95質量%、更佳為70質量%~99.9質量%、尤佳為75質量%~99.8質量%。The content of the triglyceride in the content is not limited, and it can be exemplified: preferably 60% by mass to 99.95% by mass, more preferably 70% by mass to 99.9% by mass, and particularly preferably 75% by mass to 99.8% by mass.

雖於該限度內並無限制,但於內容物含有薄荷油的情況下,該內容物中的三酸甘油酯的含量並無限制,可例示:較佳為60質量%~99.9質量%、更佳為65質量%~99.5質量%、尤佳為70質量%~99質量%。Although there is no limitation within this limit, when the content contains peppermint oil, the content of triglycerides in the content is not limited, and examples include: preferably 60% by mass to 99.9% by mass, more It is preferably 65% by mass to 99.5% by mass, particularly preferably 70% by mass to 99% by mass.

雖於該限度內並無限制,但於內容物含有香芹籽油的情況下,該內容物中的三酸甘油酯的含量並無限制,可例示:較佳為65質量%~99.95質量%、更佳為70質量%~99.9質量%、尤佳為75質量%~99.8質量%。Although there is no limitation within this limit, when the content contains caraway oil, the content of triglycerides in the content is not limited, and it can be exemplified: preferably 65% by mass to 99.95% by mass , It is more preferably 70% by mass to 99.9% by mass, and particularly preferably 75% by mass to 99.8% by mass.

雖於該限度內並無限制,但於內容物含有薄荷酮油的情況下,該內容物中的三酸甘油酯的含量並無限制,可例示:較佳為65質量%~99質量%、更佳為70質量%~97質量%、尤佳為75質量%~95質量%。Although there is no limitation within this limit, when the content contains menthone oil, the content of triglyceride in the content is not limited, and examples include: preferably 65% by mass to 99% by mass, It is more preferably 70% by mass to 97% by mass, and particularly preferably 75% by mass to 95% by mass.

於不損及本發明的效果的範圍內,於內容物中視需要亦可還含有藥學上所容許的成分、香妝學上所容許的成分、可食性的成分等任意成分。作為該成分,可較佳地列舉能夠可食的成分。As long as the effect of the present invention is not impaired, the content may further contain optional ingredients such as pharmaceutically acceptable ingredients, cosmetically acceptable ingredients, and edible ingredients, if necessary. As this component, the edible component can be mentioned suitably.

作為該任意成分,可例示:水、塑化劑、著色料、胺基酸、維生素類、酶、甜味料、清涼劑、香料、賦形劑、崩解劑、流化劑、界面活性劑、矯味劑、矯臭劑、懸浮劑、潤濕劑、乳化劑、助溶劑、分散劑、緩衝劑、結合劑、滲透促進劑、穩定劑、增量劑、防腐劑、增黏劑、pH調整劑、塗佈劑、吸收促進劑、抗氧化劑、抗炎症劑、蠟、各種有用成分等。它們可單獨使用一種,亦可組合使用兩種以上,只要不損及本發明的效果,則其含量亦可適宜決定。Examples of the optional ingredients include water, plasticizers, colorants, amino acids, vitamins, enzymes, sweeteners, cooling agents, fragrances, excipients, disintegrants, fluidizing agents, and surfactants , Flavoring agents, flavoring agents, suspending agents, wetting agents, emulsifiers, cosolvents, dispersants, buffers, binding agents, penetration enhancers, stabilizers, extenders, preservatives, tackifiers, pH adjusters , Coating agents, absorption enhancers, antioxidants, anti-inflammatory agents, waxes, various useful ingredients, etc. These may be used individually by 1 type, and may be used in combination of 2 or more types, and as long as the effect of this invention is not impaired, the content can also be suitably determined.

內容物的形態並無限制,可為固體狀(粉末狀、顆粒狀等)、半固體狀(凝膠狀(膠狀)、霜狀、膏狀等)、液狀等任一種。作為內容物的形態,可較佳地例示半固體狀或液狀。The form of the content is not limited, and it may be solid (powder, granular, etc.), semi-solid (gel (gel), cream, paste, etc.), liquid, etc. As the form of the content, a semi-solid form or a liquid form can be preferably exemplified.

內容物可依據以往公知的膠囊劑中所內包的內容物的製造程序來製造,例如可將選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種、視需要的三酸甘油酯及進而視需要的所述任意成分適宜混合來製備。The content can be manufactured according to the conventionally known manufacturing process of the content contained in the capsule. For example, at least one selected from the group consisting of peppermint oil, caraway oil, and menthone oil can be selected as needed. The triglyceride and the optional components described above are appropriately mixed to prepare.

皮膜 另外,於本發明的膠囊劑中,皮膜含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種。Coating In addition, in the capsule of the present invention, the film contains at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin.

源自豬的明膠或源自魚的明膠只要是以往用於食品、醫藥品、準藥品等領域中的明膠即可,可較佳地例示可食性的明膠。雖於該限度內並無限制,但作為該明膠,可例示:以豬或魚的皮、骨、腱、韌帶、鱗等為原料的經酸及/或鹼處理的明膠、醯化明膠等化學修飾明膠、明膠的水解物等明膠。該些明膠可單獨使用一種,亦可組合使用兩種以上。源自豬的明膠或源自魚的明膠可商業性獲取,例如由尼皮(NIPPI)股份有限公司、新田明膠股份有限公司、傑拉伊思(JELLICE)股份有限公司、羅賽洛(Rousselot)公司、威薩德(Weishardt)公司等市售。Porcine-derived gelatin or fish-derived gelatin may be gelatin conventionally used in the fields of food, medicine, quasi-drugs, and the like, and edible gelatin can be preferably exemplified. Although there is no limitation within this limit, as the gelatin, there can be exemplified: chemically treated gelatin, acylated gelatin, etc., using the skin, bone, tendon, ligament, scale, etc. of pig or fish as raw materials Modified gelatin, gelatin hydrolysate and other gelatin. These gelatins may be used alone or in combination of two or more. Pig-derived gelatin or fish-derived gelatin can be obtained commercially, for example, from NIPPI Co., Ltd., Nitta Gelatin Co., Ltd., JELLICE Co., Ltd., Rousselot (Rousselot) ) Company, Weisardt (Weishardt) company and other commercially available.

源自豬的明膠或源自魚的明膠雖於該限度內並無限制,但可適宜選擇該明膠的膠強度(布盧姆(Bloom)值)來使用。雖並不限制本發明,但明膠的膠強度可例示:較佳為50 g~350 g、更佳為80 g~300 g的範圍。明膠的膠強度可依據日本工業標準(Japanese Industrial Standards,JIS)K-6503(2001)來測定,具體而言,將利用二分之一英寸(12.7 mm)徑的柱塞對膠的表面往下壓4 mm時所需的荷重(g)設為膠強度,所述膠是將6.67質量%的明膠水溶液於10℃下冷卻17小時而製備。Although the gelatin derived from pig or the gelatin derived from fish is not limited within this limit, the gel strength (Bloom value) of the gelatin can be appropriately selected and used. Although the present invention is not limited, the gel strength of gelatin can be exemplified: it is preferably in the range of 50 g to 350 g, more preferably in the range of 80 g to 300 g. The gel strength of gelatin can be measured in accordance with Japanese Industrial Standards (JIS) K-6503 (2001). Specifically, a 1/2 inch (12.7 mm) diameter plunger will be used to lower the surface of the gel. The load (g) required at the time of pressing 4 mm was defined as the strength of the gel, which was prepared by cooling a 6.67% by mass aqueous gelatin solution at 10°C for 17 hours.

皮膜中的選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的含量並無限制,選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種可例示:於皮膜中以總量計較佳為15質量%~85質量%、更佳為20質量%~80質量%、尤佳為25質量%~75質量%。The content of at least one selected from the group consisting of pig-derived gelatin and fish-derived gelatin in the film is not limited, and is selected from the group consisting of pig-derived gelatin and fish-derived gelatin At least one type of is exemplified: preferably 15% by mass to 85% by mass, more preferably 20% by mass to 80% by mass, and particularly preferably 25% by mass to 75% by mass in the total amount in the film.

另外,雖並不限制本發明,但相對於選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的總量100質量份,選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種可例示:以總量計較佳為1質量份~50質量份、更佳為3質量份~45質量份、尤佳為5質量份~35質量份。In addition, although the present invention is not limited, relative to 100 parts by mass of the total amount of at least one selected from the group consisting of pig-derived gelatin and fish-derived gelatin, it is selected from peppermint oil and caraway oil And at least one of the group consisting of menthone oil can be exemplified: the total amount is preferably 1 part by mass to 50 parts by mass, more preferably 3 parts by mass to 45 parts by mass, particularly preferably 5 parts by mass to 35 parts by mass Copies.

於不損及本發明的效果的範圍內,於皮膜中視需要亦可還含有藥學上所容許的成分、香妝學上所容許的成分、可食性的成分等任意成分。作為該成分,可較佳地列舉能夠可食的成分。As long as the effect of the present invention is not impaired, optional ingredients such as pharmacologically acceptable ingredients, cosmetically acceptable ingredients, and edible ingredients may be further contained in the film as needed. As this component, the edible component can be mentioned suitably.

作為該任意成分,可例示:水、塑化劑、賦形劑、崩解劑、流化劑、界面活性劑、潤滑劑、香料、著色料、甜味料、矯味劑、矯臭劑、懸浮劑、潤濕劑、乳化劑、助溶劑、分散劑、緩衝劑、結合劑、滲透促進劑、穩定劑、增量劑、防腐劑、增黏劑、油性基劑、pH調整劑、塗佈劑、吸收促進劑、抗氧化劑、抗炎症劑、清涼劑、胺基酸、維生素類、酶、各種有用成分等。它們可單獨使用一種,亦可組合使用兩種以上,只要不損及本發明的效果,其含量亦可適宜決定。再者,雖並不限制本發明,但較佳為本發明中的皮膜不含源自牛的明膠。Examples of such optional ingredients include: water, plasticizers, excipients, disintegrants, fluidizers, surfactants, lubricants, fragrances, colorants, sweeteners, correctives, correctives, and suspending agents , Wetting agents, emulsifiers, co-solvents, dispersants, buffers, binding agents, penetration enhancers, stabilizers, extenders, preservatives, tackifiers, oily bases, pH adjusters, coating agents, Absorption enhancers, antioxidants, anti-inflammatory agents, cooling agents, amino acids, vitamins, enzymes, various useful ingredients, etc. These may be used singly or in combination of two or more, and the content may be appropriately determined as long as the effects of the present invention are not impaired. Furthermore, although the present invention is not limited, it is preferable that the film in the present invention does not contain bovine-derived gelatin.

雖並不限制本發明,但對作為該任意成分的一例的塑化劑進行說明時,作為塑化劑,可例示:甘油;丙二醇或聚乙二醇等二醇類;蔗糖、果糖、山梨糖醇、甘露醇、玉米糖漿等液狀糖類;結晶纖維素、低取代度羥基丙基纖維素、乙基纖維素等水不溶性纖維素等。它們均可單獨使用一種,亦可組合使用兩種以上。另外,皮膜中的塑化劑的含量並無限制,可例示:較佳為1質量%~45質量%、更佳為5質量%~35質量%、尤佳為10質量%~30質量%。Although the present invention is not limited, when describing the plasticizer as an example of the optional component, examples of the plasticizer include: glycerin; glycols such as propylene glycol or polyethylene glycol; sucrose, fructose, and sorbose Liquid sugars such as alcohol, mannitol, and corn syrup; water-insoluble cellulose such as crystalline cellulose, low-substituted hydroxypropyl cellulose, ethyl cellulose, etc. These can be used individually by 1 type, and can also be used in combination of 2 or more types. In addition, the content of the plasticizer in the film is not limited, and examples thereof are preferably 1% to 45% by mass, more preferably 5% to 35% by mass, and particularly preferably 10% to 30% by mass.

皮膜可依據以往公知的膠囊劑中所使用的皮膜的製造程序來製造,例如,可將選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種與視需要的所述任意成分適宜混合來製備。The film can be manufactured according to the manufacturing process of the film used in conventionally known capsules. For example, at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin can be selected from the group consisting of gelatin derived from pigs and gelatin derived from fish. The optional ingredients are suitably mixed to prepare.

膠囊劑 於本發明中,膠囊劑中,所述內容物內包於所述皮膜中。膠囊劑可依據以往公知的膠囊劑的製造程序來製造,例如可藉由如下方式來製造:將選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種、視需要的三酸甘油酯及進而視需要的所述任意成分適宜混合而製備的內容物內包於皮膜(膠囊)中,所述皮膜(膠囊)是將選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種與視需要的所述任意成分適宜混合而製備。本發明的膠囊劑可藉由如下方式來製造:依據將內容物填充於皮膜內或利用皮膜外包內容物等以往公知的膠囊劑的製造程序來將內容物內包於皮膜中。Capsules In the present invention, in the capsule, the content is contained in the film. Capsules can be manufactured according to conventionally known capsule manufacturing procedures. For example, they can be manufactured by adding at least one selected from the group consisting of peppermint oil, caraway oil, and menthone oil, as required The content prepared by mixing the triglycerides and the optional ingredients as required is enclosed in a film (capsule) which is selected from porcine-derived gelatin and fish-derived At least one of the group consisting of gelatin is appropriately mixed with the optional ingredients as needed to prepare. The capsule of the present invention can be manufactured by enclosing the contents in the film according to a conventionally known manufacturing procedure of capsules such as filling the contents in the film or wrapping the contents with the film.

本發明的膠囊劑可為軟膠囊劑,亦可為硬膠囊劑。另外,雖並不限制本發明,但作為膠囊劑的形狀,可例示橢圓(橄欖球)型、長橢圓(oblong)型、圓(球狀)型、淚型、三角形等,只要可較佳地服用,則其大小亦並無限制,例如,於橢圓型的情況下,可列舉:較佳為長徑6 mm~20 mm、短徑4 mm~15 mm,更佳為長徑6 mm~15 mm、短徑4 mm~10 mm。The capsule of the present invention may be a soft capsule or a hard capsule. In addition, although the present invention is not limited, as the shape of the capsule, there can be exemplified an oval (rugby) type, an oblong type, a round (spherical) type, a tear type, a triangle, etc., as long as it can be taken preferably , There is no limit to its size. For example, in the case of an ellipse, it can be listed as follows: preferably the long diameter is 6 mm-20 mm, the short diameter is 4 mm-15 mm, and the long diameter is 6 mm-15 mm. , The short diameter is 4 mm~10 mm.

本發明的膠囊劑可以經口、非經口的任一者的形式使用,較佳為以經口的形式使用。膠囊劑的使用態樣並無限制,可根據目的來適宜設定。作為該使用態樣,例示以經口的形式使用的情況時,可作為食品組成物(包含飲料,且包含保健功能食品(包含特定保健用食品、營養功能食品、功能性表示食品、補充品等)、健康輔助食品、病人用食品)、醫藥組成物、準藥品組成物、飼料組成物以及對於食品組成物、醫藥組成物、準藥品組成物、飼料等的添加劑等使用。本發明的膠囊劑例如可為迅速吞下者,亦可為預先於口腔內停留一定時間,其後吞下者。The capsule of the present invention can be used in either oral or parenteral form, and is preferably used in an oral form. There is no limitation on the usage of the capsule, and it can be appropriately set according to the purpose. As an example of this usage, when it is used in oral form, it can be used as a food composition (including beverages and health functional foods (including specific health foods, nutritional functional foods, functional foods, supplements, etc.) ), health supplementary food, food for patients), medical composition, quasi-drug composition, feed composition, and additives for food composition, medical composition, quasi-drug composition, feed, etc. The capsule of the present invention may be, for example, one that can be swallowed quickly, or one that stays in the oral cavity for a certain period of time before swallowing.

應用(攝取、給藥等)本發明的膠囊劑的對象者亦並無限制,可例示人類、人類以外的哺乳動物。作為人類以外的哺乳動物,可例示:豚鼠、兔子、狗、貓、猴子、黑猩猩等動物。The subjects to whom the capsule of the present invention is applied (ingestion, administration, etc.) are also not limited, and humans and mammals other than humans can be exemplified. Examples of mammals other than humans include animals such as guinea pigs, rabbits, dogs, cats, monkeys, and chimpanzees.

根據本發明的膠囊劑,使用選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種,藉此可有效地抑制含有源自豬的明膠或源自魚的明膠的皮膜的不溶化。According to the capsule of the present invention, at least one selected from the group consisting of peppermint oil, caraway oil and menthone oil is used, thereby effectively suppressing the content of gelatin derived from pig or gelatin derived from fish. Insoluble film.

因此,還可以說本發明提供一種所述皮膜的不溶化抑制方法,其特徵在於:於具有內容物及內包所述內容物的皮膜的膠囊劑中,將含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種的內容物、與含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的皮膜組合。於該方法中,關於選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種、選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種、內容物、皮膜、膠囊劑等,與上文所述同樣地進行說明。因此,可以說該方法可藉由如下方式來實施:將含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種的內容物內包於皮膜中,所述皮膜含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種。Therefore, it can also be said that the present invention provides a method for inhibiting the insolubilization of the film, which is characterized in that: a capsule having a content and a film encapsulating the content will contain selected from peppermint oil and caraway oil And at least one of the contents of menthone oil, and a film containing at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin. In this method, at least one selected from the group consisting of peppermint oil, caraway oil, and menthone oil, at least one selected from the group consisting of pig-derived gelatin and fish-derived gelatin One, the content, the film, the capsule, etc. will be described in the same manner as described above. Therefore, it can be said that the method can be carried out by enclosing the contents containing at least one selected from the group consisting of peppermint oil, caraway oil, and menthone oil in a film, the film It contains at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin.

根據本發明,如上所述可抑制含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的皮膜的不溶化,進而可更適當地放出膠囊劑中所含的有效成分。 [實施例]According to the present invention, as described above, the insolubilization of the film containing at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin can be suppressed, and the effective release contained in the capsule can be more appropriately released. ingredient. [Example]

以下,示出實施例而對本發明進行更詳細說明,但本發明並不限定於該些。Hereinafter, the present invention will be described in more detail by showing examples, but the present invention is not limited to these.

試驗例 內容物及皮膜的製備 依據如下表1的組成,將薄荷油與三酸甘油酯混合而獲得透明的液體作為內容物(實施例1~實施例6、比較例1~比較例3)。除使用薄荷酮油來代替薄荷油以外,與上文所述同樣地,依據如下表2的組成而獲得透明的液體(實施例7~實施例12、比較例4~比較例6)。除使用香芹籽油來代替薄荷油以外,與上文所述同樣地,依據如下表3的組成而獲得透明的液體(實施例13~實施例18、比較例7~比較例9)。除使用薄荷香料或檸檬香料來代替薄荷油以外,與上文所述同樣地,依據如下表4的組成而獲得透明的液體(比較例10~比較例15)。所獲得的任一液體中,均未目視確認到固體物。Test example Preparation of contents and film According to the composition of Table 1 below, peppermint oil and triglycerides were mixed to obtain a transparent liquid as the content (Example 1 to Example 6, Comparative Example 1 to Comparative Example 3). Except for using menthone oil instead of peppermint oil, in the same manner as described above, a transparent liquid was obtained based on the composition of the following Table 2 (Example 7 to Example 12, Comparative Example 4 to Comparative Example 6). Except for using caraway oil instead of peppermint oil, in the same manner as described above, a transparent liquid was obtained based on the composition of the following Table 3 (Example 13 to Example 18, Comparative Example 7 to Comparative Example 9). Except for using peppermint flavor or lemon flavor instead of peppermint oil, in the same manner as described above, a transparent liquid was obtained based on the composition of the following Table 4 (Comparative Example 10 to Comparative Example 15). In any of the obtained liquids, no solid matter was visually confirmed.

另行,將10 g的源自豬的明膠、20 g的水及4 g的甘油混合,將明膠加熱溶解(80℃),繼而進行冷卻(25℃),將冷卻物裁切為每一枚1.5 cm×1.5 cm(重量80 mg)的片材,從而製作包含源自豬的明膠的皮膜片(豬明膠皮膜片)。除將源自豬的明膠替換為源自魚的明膠、源自牛的明膠以外,同樣地製作包含源自魚的明膠的皮膜片(魚明膠皮膜片)、包含源自牛的明膠的皮膜片(牛明膠皮膜片)。Separately, mix 10 g of porcine-derived gelatin, 20 g of water, and 4 g of glycerin, heat and dissolve the gelatin (80°C), then cool it (25°C), and cut the cooling material into 1.5 pieces each cm×1.5 cm (weight 80 mg) to produce a skin sheet (pig gelatin skin sheet) containing porcine-derived gelatin. Except for replacing pig-derived gelatin with fish-derived gelatin and cow-derived gelatin, a skin sheet (fish gelatin skin sheet) containing fish-derived gelatin and a skin sheet containing bovine-derived gelatin were similarly produced. (Bovine Gelatin Skin Film).

再者,薄荷油使用商品名薄荷白油(長岡實業股份有限公司製造),薄荷酮油使用商品名薄荷酮油95%(長岡實業股份有限公司製造),香芹籽油使用商品名香芹籽油(香榮興業股份有限公司製造),薄荷香料使用商品名留蘭香油(Spearmint oil)(高砂香料工業股份有限公司製造),檸檬香料使用商品名檸檬油(小川香料股份有限公司製造),三酸甘油酯使用商品名J向日葵精油(J-油米爾斯(Oil Mills)股份有限公司製造)。再者,向日葵油通常含有約95質量%~100質量%的三酸甘油酯,含有包含油酸及亞麻油酸作為主要的構成脂肪酸的三酸甘油酯。In addition, the brand name peppermint oil (manufactured by Nagaoka Industrial Co., Ltd.) is used for peppermint oil, 95% brand name menthone oil (manufactured by Nagaoka Industrial Co., Ltd.) is used for peppermint oil, and the brand name caraway is used for parsley oil. Oil (manufactured by Xiangrong Industrial Co., Ltd.), brand name Spearmint oil (manufactured by Takasago Fragrance Industry Co., Ltd.) for mint fragrance, brand name lemon oil (manufactured by Ogawa Fragrance Co., Ltd.) for lemon fragrance, three As the acid glyceride, the brand name J sunflower essential oil (manufactured by J-oil Mills (Oil Mills) Co., Ltd.) was used. Furthermore, sunflower oil usually contains about 95% to 100% by mass of triglycerides, and contains triglycerides containing oleic acid and linoleic acid as main constituent fatty acids.

源自豬的明膠使用商品名KKSC(根據製造公司而記載的膠強度(以下相同)250 g~280 g),源自魚的明膠使用商品名SCG-230L(膠強度230 g~270 g),源自牛的明膠使用商品名#250(膠強度235 g~265 g)(均為新田明膠股份有限公司製造)。膠強度為依據JIS K-6503(2001)進行測定而得的值,具體而言為利用二分之一英寸(12.7 mm)徑的柱塞對膠的表面往下壓4 mm時所需的荷重(g),所述膠是將6.67質量%的明膠水溶液於10℃下冷卻17小時而製備。The pig-derived gelatin uses the trade name KKSC (the gel strength described by the manufacturer (the same below) 250 g ~ 280 g), and the fish-derived gelatin uses the trade name SCG-230L (the gel strength 230 g ~ 270 g). The cow-derived gelatin uses trade name #250 (gel strength 235 g~265 g) (all manufactured by Xintian Gelatin Co., Ltd.). Glue strength is a value measured in accordance with JIS K-6503 (2001). Specifically, it is the load required when a plunger with a diameter of one-half inch (12.7 mm) is used to press down on the surface of the glue 4 mm. (G), the glue is prepared by cooling a 6.67 mass% gelatin aqueous solution at 10°C for 17 hours.

於製作所述內容物及皮膜片後,進行以下的不溶化試驗。將以所述方式製作的明膠皮膜片1枚於以所述方式製作的各內容物4 mL(50℃)中以靜置的形式完全浸漬1周。繼而,將明膠皮膜片自內容物中取出,利用己烷進行清洗,然後將明膠皮膜片完全浸漬於60℃的水50 mL中(使用50 mL的燒杯),使用攪拌器攪拌5分鐘(轉速670 rpm)。繼而,於靜止狀態下進行目視觀察,以如下方式進行明膠皮膜片的不溶化的評價。再者,利用己烷清洗後的(水浸漬前的)明膠皮膜片均於內容物中維持浸漬前的形狀。After the content and the film sheet were produced, the following insolubilization test was performed. One piece of the gelatin skin film prepared in the manner described above was completely immersed in 4 mL (50°C) of each content prepared in the manner described above in a static state for 1 week. Then, the gelatin film was taken out of the content, washed with hexane, and then the gelatin film was completely immersed in 50 mL of 60°C water (using a 50 mL beaker), and stirred with a stirrer for 5 minutes (rotation speed 670 rpm). Then, visual observation was performed in a static state, and the insolubilization of the gelatin film sheet was evaluated as follows. In addition, all the gelatin film sheets washed with hexane (before water immersion) maintained the shape before immersion in the content.

<評價> ◎:明膠皮膜片完全溶解,完全未確認到不溶物。 ○:明膠皮膜片雖溶解,但確認到稍許(與即將進行水浸漬前的明膠皮膜的質量相比,10質量%以下的不溶物)不溶物。 △:明膠皮膜片雖溶解,但確認到較多的(與即將進行水浸漬前的明膠皮膜的質量相比,多於10質量%、50質量%以下的不溶物)不溶物。 ×:明膠皮膜片基本不溶解,確認到非常多的(與即將進行水浸漬前的明膠皮膜的質量相比,多於50質量%的不溶物)不溶物。<Evaluation> ◎: The gelatin film sheet was completely dissolved, and no insoluble matter was confirmed at all. ○: Although the gelatin film sheet was dissolved, slightly (insoluble matter of 10% by mass or less compared with the mass of the gelatin film immediately before water immersion) was confirmed to be insoluble. △: Although the gelatin film sheet is dissolved, many insoluble materials (more than 10% by mass and 50% by mass or less of insoluble matter compared to the mass of the gelatin film immediately before water immersion) are confirmed. ×: The gelatin film sheet is almost insoluble, and very many insolubles (more than 50% by mass of insoluble matter compared with the mass of the gelatin film immediately before water immersion) are confirmed.

結果 將結果示於表1~表4中。result The results are shown in Tables 1 to 4.

[表1]   實施例1 實施例2 實施例3 實施例4 實施例5 實施例6 比較例1 比較例2 比較例3 明膠皮膜 豬明膠 豬明膠 豬明膠 魚明膠 魚明膠 魚明膠 牛明膠 牛明膠 牛明膠 內容物 (質量%) 三酸甘油酯 99 90 80 99 90 80 99 90 80 薄荷油 1 10 20 1 10 20 1 10 20 合計 100 100 100 100 100 100 100 100 100 評價結果(不溶化抑制) × × 表中,「豬明膠」為源自豬的明膠皮膜片,「魚明膠」為源自魚的明膠皮膜片,「牛明膠」為源自牛的明膠皮膜片。[Table 1] Example 1 Example 2 Example 3 Example 4 Example 5 Example 6 Comparative example 1 Comparative example 2 Comparative example 3 Gelatin Film Porcine Gelatin Porcine Gelatin Porcine Gelatin Fish gelatin Fish gelatin Fish gelatin Bovine gelatin Bovine gelatin Bovine gelatin Contents (mass%) Triglyceride 99 90 80 99 90 80 99 90 80 peppermint 1 10 20 1 10 20 1 10 20 total 100 100 100 100 100 100 100 100 100 Evaluation result (insolubilization inhibition) × × In the table, "pig gelatin" is a gelatin skin film derived from pigs, "fish gelatin" is a gelatin skin film derived from fish, and "bovine gelatin" is a gelatin skin film derived from cattle.

[表2]   實施例7 實施例8 實施例9 實施例10 實施例11 實施例12 比較例4 比較例5 比較例6 明膠皮膜 豬明膠 豬明膠 豬明膠 魚明膠 魚明膠 魚明膠 牛明膠 牛明膠 牛明膠 內容物 (質量%) 三酸甘油酯 95 85 80 95 85 80 95 85 80 薄荷酮油 5 15 20 5 15 20 5 15 20 合計 100 100 100 100 100 100 100 100 100 評價結果(不溶化抑制) × × [Table 2] Example 7 Example 8 Example 9 Example 10 Example 11 Example 12 Comparative example 4 Comparative example 5 Comparative example 6 Gelatin Film Porcine Gelatin Porcine Gelatin Porcine Gelatin Fish gelatin Fish gelatin Fish gelatin Bovine gelatin Bovine gelatin Bovine gelatin Contents (mass%) Triglyceride 95 85 80 95 85 80 95 85 80 Menthone Oil 5 15 20 5 15 20 5 15 20 total 100 100 100 100 100 100 100 100 100 Evaluation result (insolubilization inhibition) × ×

[表3]   實施例13 實施例14 實施例15 實施例16 實施例17 實施例18 比較例7 比較例8 比較例9 明膠皮膜 豬明膠 豬明膠 豬明膠 魚明膠 魚明膠 魚明膠 牛明膠 牛明膠 牛明膠 內容物 (質量%) 三酸甘油酯 99.8 90 80 99.8 90 80 99.8 90 80 香芹籽油 0.2 10 20 0.2 10 20 0.2 10 20 合計 100 100 100 100 100 100 100 100 100 評價結果(不溶化抑制) × × [table 3] Example 13 Example 14 Example 15 Example 16 Example 17 Example 18 Comparative example 7 Comparative example 8 Comparative example 9 Gelatin Film Porcine Gelatin Porcine Gelatin Porcine Gelatin Fish gelatin Fish gelatin Fish gelatin Bovine gelatin Bovine gelatin Bovine gelatin Contents (mass%) Triglyceride 99.8 90 80 99.8 90 80 99.8 90 80 Parsley oil 0.2 10 20 0.2 10 20 0.2 10 20 total 100 100 100 100 100 100 100 100 100 Evaluation result (insolubilization inhibition) × ×

[表4]   比較例10 比較例11 比較例12 比較例13 比較例14 比較例15 明膠皮膜 豬明膠 魚明膠 牛明膠 豬明膠 魚明膠 牛明膠 內容物 (質量%) 三酸甘油酯 80 80 80 80 80 80 薄荷香料 20 20 20 - - - 檸檬香料 - - - 20 20 20 合計 100 100 100 100 100 100 評價結果(不溶化抑制) × × × × × × [Table 4] Comparative example 10 Comparative example 11 Comparative example 12 Comparative example 13 Comparative example 14 Comparative example 15 Gelatin Film Porcine Gelatin Fish gelatin Bovine gelatin Porcine Gelatin Fish gelatin Bovine gelatin Contents (mass%) Triglyceride 80 80 80 80 80 80 Mint spice 20 20 20 - - - Lemon spice - - - 20 20 20 total 100 100 100 100 100 100 Evaluation result (insolubilization inhibition) × × × × × ×

如使用薄荷油的表1的比較例1~比較例3所示,於使用牛明膠皮膜片作為皮膜片的情況下,確認到大量的皮膜片的不溶物。相對於此,如表1的實施例1~實施例6所示,於使用豬明膠皮膜片、魚明膠皮膜片作為皮膜片的情況下,基本未確認到皮膜片的不溶物。根據該些結果可知,薄荷油於豬明膠皮膜或魚明膠皮膜的不溶化抑制方面優異。As shown in Comparative Example 1 to Comparative Example 3 of Table 1 using peppermint oil, when a bovine gelatin film sheet was used as the film sheet, a large amount of insoluble matter of the film sheet was confirmed. In contrast, as shown in Examples 1 to 6 in Table 1, when a pig gelatin skin film sheet or a fish gelatin skin film sheet was used as the skin film sheet, the insoluble matter of the skin film sheet was hardly confirmed. From these results, it can be seen that peppermint oil is excellent in inhibiting the insolubilization of a pig gelatin film or a fish gelatin film.

另外,於使用薄荷酮油的表2中,如比較例4~比較例6所示,於使用牛明膠皮膜片作為皮膜片的情況下,確認到大量的皮膜片的不溶物。相對於此,如實施例7~實施例12所示,於使用豬明膠皮膜片、魚明膠皮膜片作為皮膜片的情況下,基本未確認到皮膜片的不溶物。根據該些結果可知,薄荷酮油於豬明膠皮膜或魚明膠皮膜的不溶化抑制方面亦優異。In addition, in Table 2 using menthone oil, as shown in Comparative Examples 4 to 6, when a bovine gelatin film sheet was used as the film sheet, a large amount of insoluble matter of the film sheet was confirmed. In contrast, as shown in Examples 7 to 12, when a pig gelatin skin film sheet or a fish gelatin skin film sheet was used as the skin film sheet, the insoluble matter of the skin film sheet was hardly confirmed. From these results, it can be seen that menthone oil is also excellent in inhibiting the insolubilization of a pig gelatin film or a fish gelatin film.

另外,於使用香芹籽油的表3中,如比較例7~比較例9所示,於使用牛明膠皮膜片作為皮膜片的情況下,確認到大量的皮膜片的不溶物。相對於此,如實施例13~實施例18所示,於使用豬明膠皮膜片、魚明膠皮膜片作為皮膜片的情況下,基本未確認到皮膜片的不溶物。根據該些結果可知,香芹籽油於豬明膠皮膜或魚明膠皮膜的不溶化抑制方面亦優異。In addition, in Table 3 using caraway oil, as shown in Comparative Examples 7 to 9, when a bovine gelatin skin sheet was used as a skin sheet, a large amount of insoluble matter of the skin sheet was confirmed. On the other hand, as shown in Examples 13 to 18, when a pig gelatin skin film sheet or a fish gelatin skin film sheet was used as the skin film sheet, the insoluble matter of the skin film sheet was hardly confirmed. From these results, it can be seen that caraway oil is also excellent in inhibiting the insolubilization of a pig gelatin film or a fish gelatin film.

另一方面,使用薄荷香料或檸檬香料的表4中,即便為豬明膠皮膜片(比較例10及比較例13)、魚明膠皮膜片(比較例11及比較例14)、牛明膠皮膜片(比較例12及比較例15)的任一者,亦確認到大量的皮膜片的不溶物。On the other hand, in Table 4 using mint flavor or lemon flavor, even pig gelatin skin films (Comparative Examples 10 and 13), fish gelatin skin films (Comparative Examples 11 and 14), and bovine gelatin skin films ( In any of Comparative Example 12 and Comparative Example 15), a large amount of insoluble matter of the membrane sheet was also confirmed.

因此,確認到薄荷油、薄荷酮油、香芹籽油於包含源自豬的明膠或源自魚的明膠的皮膜的不溶化抑制方面優異。Therefore, it was confirmed that peppermint oil, menthone oil, and caraway oil are excellent in inhibiting the insolubilization of a film containing porcine-derived gelatin or fish-derived gelatin.

no

no

Claims (6)

一種膠囊劑,其特徵在於:於皮膜中內包有內容物,所述皮膜含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種,所述內容物含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種。A capsule, characterized in that: a content is enclosed in a skin film containing at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin, and the content contains selected At least one of the group consisting of free peppermint oil, caraway oil and menthone oil. 如請求項1所述的膠囊劑,其中所述內容物更含有三酸甘油酯,所述內容物中,相對於所述三酸甘油酯100質量份而含有28質量份以下的薄荷油。The capsule according to claim 1, wherein the content further contains triglycerides, and the content contains 28 parts by mass or less of peppermint oil with respect to 100 parts by mass of the triglycerides. 如請求項1或請求項2所述的膠囊劑,其中所述內容物更含有三酸甘油酯,所述內容物中,相對於所述三酸甘油酯100質量份而含有28質量份以下的香芹籽油。The capsule according to claim 1 or claim 2, wherein the content further contains triglycerides, and the content contains 28 parts by mass or less relative to 100 parts by mass of the triglycerides Parsley oil. 如請求項1至請求項3中任一項所述的膠囊劑,其中所述內容物更含有三酸甘油酯,所述內容物中,相對於所述三酸甘油酯100質量份而含有28質量份以下的薄荷酮油。The capsule according to any one of claims 1 to 3, wherein the content further contains triglycerides, and the content contains 28 parts by mass relative to 100 parts by mass of the triglycerides. Menthone oil in parts by mass or less. 如請求項1至請求項4中任一項所述的膠囊劑,其為軟膠囊劑。The capsule according to any one of claims 1 to 4, which is a soft capsule. 一種皮膜的不溶化抑制方法,其特徵在於:於具有內容物及內包所述內容物的皮膜的膠囊劑中,將含有選自由薄荷油、香芹籽油及薄荷酮油所組成的群組中的至少一種的內容物、與含有選自由源自豬的明膠及源自魚的明膠所組成的群組中的至少一種的皮膜組合。A method for inhibiting insolubilization of a film, which is characterized in that: a capsule having a content and a film encapsulating the content is selected from the group consisting of peppermint oil, caraway oil and menthone oil The content of at least one of and a film containing at least one selected from the group consisting of porcine-derived gelatin and fish-derived gelatin.
TW108145625A 2018-12-28 2019-12-13 Capsule TW202027731A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018247735A JP7362248B2 (en) 2018-12-28 2018-12-28 capsules
JP2018-247735 2018-12-28

Publications (1)

Publication Number Publication Date
TW202027731A true TW202027731A (en) 2020-08-01

Family

ID=71129774

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108145625A TW202027731A (en) 2018-12-28 2019-12-13 Capsule

Country Status (3)

Country Link
JP (1) JP7362248B2 (en)
TW (1) TW202027731A (en)
WO (1) WO2020137694A1 (en)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07550B2 (en) * 1988-09-13 1995-01-11 大正製薬株式会社 Essential oil containing soft capsule
ES2134743B1 (en) * 1998-02-06 2000-05-01 Biocosmetics Sl COMPOSITION FOR THE TREATMENT OF HALITOSIS.
KR100490279B1 (en) * 2002-07-18 2005-05-17 주식회사 서흥캅셀 Gelatin softcapsule having the properties of removal of oral smell and clearing of oral cavity
GB0303113D0 (en) * 2003-02-12 2003-03-19 Mw Encap Ltd Encapsulated flavouring for foods
JP2007523904A (en) * 2004-02-17 2007-08-23 シムライズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツト・ゲゼルシヤフト Coated spherical seamless filling capsule
JP5183104B2 (en) * 2006-06-19 2013-04-17 森下仁丹株式会社 Multiple soft capsules for bad breath removal
JP5828658B2 (en) * 2011-03-31 2015-12-09 小林製薬株式会社 Oral deodorant composition
WO2013100013A1 (en) * 2011-12-28 2013-07-04 富士カプセル株式会社 Soft capsule coating
JP6084468B2 (en) * 2013-01-24 2017-02-22 アリメント工業株式会社 Sterile mild sustained saliva secretion promoter, method for producing the same, and milder mild saliva secretion promoting food
JP6360339B2 (en) * 2014-03-31 2018-07-18 小林製薬株式会社 Gelatin capsule and method for producing the same

Also Published As

Publication number Publication date
JP7362248B2 (en) 2023-10-17
WO2020137694A1 (en) 2020-07-02
JP2020105140A (en) 2020-07-09

Similar Documents

Publication Publication Date Title
RU2376782C2 (en) Oil composition and food products that contain it, pharmaceutical composition and food additive
US6444242B1 (en) Microencapsulated oil or fat product
KR20120124745A (en) Method of microcapsulating phosphatidylserine
JPH09235584A (en) Oil and fat composition and food containing the same
JP2019206518A (en) Oil and fat-containing composition and oral preparation
US20100298274A1 (en) Fat containing composition
JP4703388B2 (en) Thioctic acid composition and method for producing the same
TW202027731A (en) Capsule
JP4599604B2 (en) Matrix containing bioactive phospholipid-containing components
JP4913340B2 (en) Capsule
JP6758145B2 (en) Oil composition and capsules
TW202038921A (en) Capsule
JP2005047851A (en) Ubidecarenone-containing composition
WO2022215753A1 (en) Gelatin capsule agent
JP2009079011A (en) Liquid composition for filling soft capsule
JP2015155384A (en) Composition to be filled in soft capsule and soft capsule filled with composition to be filled in soft capsule
WO2020262027A1 (en) Gelatin-containing composition and use thereof
WO2020262026A1 (en) Gelatin-containing composition and use for same
US20040137121A1 (en) Lamellar liquid crystals in viscuous oil product
CA2551119A1 (en) Lipase inhibitor
JP6843376B2 (en) Capsule coating composition and capsule
JP5875446B2 (en) Oxidation inhibiting composition and solid oral preparation or solid food
WO2021131732A1 (en) Gelatin-containing composition and method for suppressing stringiness
JP2017214342A (en) Composition for preventing or ameliorating dysuria
TW201821066A (en) Oral agent